Tamehachi Namikoshi Selected Research

Tamehachi Namikoshi Research Topics

Disease

6	Diabetic Nephropathies (Diabetic Nephropathy) 06/2014 - 01/2004
3	Albuminuria 06/2014 - 04/2008
3	Chronic Renal Insufficiency 05/2009 - 02/2008
3	Glomerulonephritis 07/2008 - 03/2004
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2008 - 10/2007
3	Wounds and Injuries (Trauma) 10/2007 - 01/2007
2	Fibrosis (Cirrhosis) 04/2008 - 01/2007
2	Hypertension (High Blood Pressure) 04/2008 - 01/2006
2	Sclerosis 02/2008 - 01/2007
2	IGA Glomerulonephritis (IGA Nephropathy) 01/2006 - 03/2004
2	Acute Kidney Injury (Acute Renal Failure) 03/2004 - 06/2003
1	Stomach Ulcer (Gastric Ulcer) 02/2016
1	Dyspepsia (Indigestion) 02/2016
1	Gastroesophageal Reflux (GERD) 02/2016
1	Arteriolosclerosis 09/2015
1	Hypertrophy 09/2009
1	Type 2 Diabetes Mellitus (MODY) 12/2008
1	Body Weight (Weight, Body) 12/2008
1	Nephritis 07/2008
1	Inflammation (Inflammations) 04/2008
1	Proteinuria 04/2008
1	Vascular System Injuries 10/2007
1	Hypercholesterolemia 10/2007
1	Renal Insufficiency (Renal Failure) 02/2007
1	Arteriosclerosis 01/2006
1	Hypoxia (Hypoxemia) 01/2006
1	Hemorrhage 01/2005
1	Membranous Glomerulonephritis (Membranous Nephropathy) 03/2004
1	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 03/2004
1	Kidney Diseases (Kidney Disease) 03/2004
1	Chronic Kidney Failure (Chronic Renal Failure) 12/2002

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 09/2009 - 12/2002
3	Streptozocin (Streptozotocin)FDA Link 06/2014 - 04/2008
3	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2009 - 06/2003
3	Angiotensin II Type 1 Receptor BlockersIBA 12/2008 - 10/2007
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 06/2014 - 04/2013
2	Dietary ProteinsIBA 05/2009 - 10/2007
2	Pioglitazone (Actos)FDA Link 04/2008 - 10/2007
1	Esomeprazole (Nexium)FDA Link 02/2016
1	Sevelamer (RenaGel)FDA Link 02/2016
1	Proton Pump InhibitorsIBA 02/2016
1	polystyrene sulfonic acid (sodium polystyrene sulfonate)FDA LinkGeneric 02/2016
1	HDL CholesterolIBA 09/2015
1	HDL LipoproteinsIBA 09/2015
1	NADPH Oxidases (NAD(P)H oxidase)IBA 06/2014
1	Apolipoproteins E (ApoE)IBA 06/2014
1	Extracellular Matrix ProteinsIBA 06/2014
1	Transforming Growth Factors (Transforming Growth Factor)IBA 04/2013
1	tempolIBA 09/2009
1	Ribosomal Protein S6IBA 09/2009
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2008
1	Nitric Oxide Synthase (NO Synthase)IBA 12/2008
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 12/2008
1	plasmin receptorIBA 07/2008
1	Heymann Nephritis Antigenic ComplexIBA 07/2008
1	Fibrinolysin FDA Link 07/2008
1	Serotonin (5 Hydroxytryptamine)IBA 04/2008
1	ThiazolidinedionesIBA 04/2008
1	candesartanIBA 04/2008
1	sarpogrelateIBA 04/2008
1	AdiponectinIBA 04/2008
1	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 04/2008
1	Superoxides (Superoxide)IBA 02/2008
1	Therapeutic UsesIBA 10/2007
1	2,4-thiazolidinedione (thiazolidinedione)IBA 10/2007
1	Hydralazine (Apresoline)FDA LinkGeneric 10/2007
1	Antihypertensive Agents (Antihypertensives)IBA 10/2007
1	olmesartanIBA 10/2007
1	Antigen-Antibody Complex (Immune Complex)IBA 02/2007
1	Hexosaminidases (Hexosaminidase)IBA 01/2007
1	CreatinineIBA 01/2007
1	TransglutaminasesIBA 01/2007
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2006
1	Transcription Factors (Transcription Factor)IBA 01/2006
1	Galectin 3 (LGALS3)IBA 03/2004
1	Chemokine CX3CL1IBA 01/2004
1	EdaravoneIBA 06/2003
1	Free Radical ScavengersIBA 06/2003
1	Cisplatin (Platino)FDA LinkGeneric 06/2003
1	Hydroxyl RadicalIBA 06/2003

Therapy/Procedure

2	Therapeutics 02/2016 - 04/2008
2	Renal Dialysis (Hemodialysis) 02/2016 - 01/2005
1	Nephrectomy 09/2009
1	High-Protein Diet 04/2008
1	Catheters 01/2005
1	Platelet Transfusion (Blood Platelet Transfusions) 01/2005